For citations:
Israelyan E.R., Rumyantsev A.A., Petrova G.D., Tyulyandina A.S., Tryakin A.A., Fedyanin M.Yu., Monin I.S., Nikiforova N.M., Tyulyandin S.A. Paclitaxel, gemcitabine, oxaliplatin regimen in induction therapy of patients with relapsed and refractory germ cell tumors before high-dose chemotherapy: results of a pilot study. Malignant tumours. 2022;12(4):14-21. (In Russ.) https://doi.org/10.18027/2224-5057-2022-12-4-14-21
Email this article 